Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07271316 · ClinicalTrials.gov registry record · Phase 2
Alii Supplement Study
A Phase 2 study of Energy and Digestive Health, sponsored by Texas Christian University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 68
- Enrollment target
- 1
- Study location
NCT07271316: Recruiting Phase 2 study of Energy and Digestive Health, sponsored by Texas Christian University.
NCT07271316 is a Phase 2 study of Energy and Digestive Health that is actively recruiting participants, run by Texas Christian University. The registered enrollment target is 68 participants, below the 855-participant average among 7 other Energy trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07271316, a Phase 2 study of Energy and Digestive Health, is actively recruiting participants, sponsored by Texas Christian University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 68 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if the Alii Supplement can be used to reduce symptoms related to nutritional depletion in hormonal birth control pill users. The main questions it aims to answer are: Does usage of the supplement increase happiness, decrease perceived vulnerability to disease, increase digestive health, decrease mood swings, and increase energy? The investigators will compare the Alii Supplement to a placebo (a capsule that contains no drug) to see if the Alii Supplement works to reduce symptoms associated with nutritional depletion. Participants will: Take the placebo or Alii Supplement everyday for 28 days and visit the research office twice to fill out an online survey comprising of items examining the main outcome measures.
Primary Outcome
Participants completed the Perceived Infectability Subscale of the Perceived Vulnerability to Disease Scale. For each scale item, 1 = Strongly disagree to 7 = Strongly agree. The subscale scores can range from 1 to 7. Higher scores indicate a higher perceived vulnerability to disease. Higher scores indicate a worse outcome. Subscale items were averaged together to create a perceived infectability score.
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Alii Supplement
Study Locations (1)
Texas
- Texas Christian University - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2026-01-12 |
| Est. Completion | 2026-04-29 |
| Phase | Phase 2 |
What NCT07271316 shows while recruiting
NCT07271316 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 855-participant average among 7 other Energy trials with a reported enrollment target (92% lower).
The record links to 6 conditions, with Energy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07271316 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07271316 about?
NCT07271316 is a clinical study titled "Alii Supplement Study". The goal of this clinical trial is to learn if the Alii Supplement can be used to reduce symptoms related to nutritional depletion in hormonal birth control pill users. The main questions it aims to answer are: Does usage of the supplement increase happiness, decrease perceived vulnerability to dis...
What is the current status of trial NCT07271316?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 68 participants. The study started on 2026-01-12. Estimated completion is 2026-04-29.
What conditions does trial NCT07271316 study?
This clinical trial studies the following conditions: Energy, Digestive Health, Nutrient Deficiency, Happiness, Vulnerability to Disease.
What interventions are being tested in trial NCT07271316?
The interventions under investigation include: Placebo (OTHER), Alii Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07271316?
This trial is sponsored by Texas Christian University, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07271316 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Energy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating Heart & Soil's Lifeblood on Iron and Energy Levels
RECRUITING · NA
-
Effects of Dynamine Ingestion on Various Indices of Sustained Energy
COMPLETED · NA
-
Radicle Energy 24: A Study of Health and Wellness Products on Fatigue and Related Health Outcomes
COMPLETED · NA
-
Evaluating the Effects of Snack Products on Energy
COMPLETED · NA
-
The Acute Effects of Liquid IV's Pre-Workout Supplement on Muscle Endurance & Strength, Energy, and Cognition
COMPLETED · NA
-
The Comparison of Energy in Take and Body Weight EXERCISE
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI